Wearable cardiac monitor company iRhythm Technologies, Inc. is facing a subpoena from the US Department of Justice’s Consumer Protection Branch, the company announced during a 4 May earnings call. This is the third time federal investigators have subpoenaed the company in less than two years.
News We’re Watching: AngelMed Becomes Avertix, 3M Layoffs, FDA Warns On COVID Test Use
This week, cardiac monitoring firm AngelMed announced its new name; Tempus nabbed FDA approval for its tumor profiling test; and iRhythm revealed that it’s been subpoenaed by the US Department of Justice.
